Is Sumatriptan safe during pregnancy?
What the FDA-approved label for Sumatriptan actually states in its Pregnancy Risk Summary — not a secondhand verdict. The decision is one to make with your prescriber.
What the label’s pregnancy summary says
The label's §8.1 Risk Summary says data from a prospective pregnancy exposure registry and epidemiological studies have not detected an increased frequency of birth defects, or a consistent pattern of birth defects, in women exposed to sumatriptan compared with the general population. It notes the registry sample was insufficient to support definitive conclusions about overall malformation risk. In animal studies, sumatriptan was associated with embryolethality, fetal abnormalities, and reduced pup survival. The label does not state a specific human fetal-harm warning, but does not declare the drug safe; decisions about use in pregnancy should be made with the prescriber.
Frequently asked questions
Is Sumatriptan safe to take during pregnancy?
The label's §8.1 does not report a clear risk for Sumatriptan (summary above), which is reassuring but is not the same as a guarantee of safety — no drug is studied in pregnancy the way it is in other adults. Use it in pregnancy only after discussing it with your prescriber. The one universal rule: do not start or stop a medication in pregnancy without medical advice — an untreated condition can carry its own risk to a pregnancy.
What does the FDA label say about Sumatriptan in pregnancy?
The summary above is transcribed from the label's Pregnancy Risk Summary (§8.1). Since 2015 FDA labels replaced the old A/B/C/D/X letter categories with a narrative that describes what human and animal data actually show, which is what you are reading here — not a single letter grade.
Is Sumatriptan safe while breastfeeding?
That is a separate question the label answers in a different section (§8.2, Lactation), and it does not always match the pregnancy verdict. This page covers pregnancy only. For breastfeeding, ask your prescriber or pharmacist, or check the NIH LactMed database, which summarizes the drug-in-breast-milk evidence.
The questions people actually ask about sumatriptan in pregnancy
Answered by MotherToBaby, the fact sheets written by the Organization of Teratology Information Specialists and published through the NIH. Quoted in full — we do not condense them.
Can having migraine headaches affect pregnancy?
Some studies have shown that women with a history of migraine headaches have a slightly higher chance for pregnancy complications including high blood pressure and preeclampsia (high blood pressure and problems with organs, such as the kidneys), which can lead to seizures (called eclampsia), and pregnancy-related stroke. Be sure to talk with your healthcare providers about your history of migraine headaches so they can monitor symptoms during pregnancy, if needed.
I take sumatriptan. Can it make it harder for me to get pregnant?
It is not known if sumatriptan can make it harder to get pregnant.
Does taking sumatriptan increase the chance of miscarriage?
Miscarriage is common and can occur in any pregnancy for many different reasons. Studies have not found an increased chance of miscarriage when sumatriptan is taken during pregnancy.
Does taking sumatriptan increase the chance of birth defects?
Birth defects can happen in any pregnancy for different reasons. Out of all babies born each year, about 3 out of 100 (3%) will have a birth defect. We look at research studies to try to understand if an exposure, like sumatriptan, might increase the chance of birth defects in a pregnancy.
Studies have not found an increased chance of birth defects when sumatriptan is taken during pregnancy.
Does taking sumatriptan in pregnancy increase the chance of other pregnancy-related problems?
Some studies have suggested a small increase in the chance of some pregnancy-related problems, including preeclampsia, preterm birth (birth before 37 weeks), low birth weight (weighing less than 5 pounds, 8 ounces [2500 grams] at birth), and heavy bleeding after delivery when sumatriptan was used late in pregnancy. However, some of these complications (including preeclampsia, preterm birth, and low birth weight) have been associated with migraines in pregnancy. This makes it hard to know if the medication, the condition being treated, or other factors are the cause of these complications.
Does taking sumatriptan in pregnancy affect future behavior or learning for the child?
No studies have looked at sumatriptan by itself to see if it can increase the chance of behavior or learning issues in children. One study looked at behavioral effects in children exposed to any triptan medication during pregnancy (including sumatriptan). At age 3, these children did not show behavior differences, except for a small increase in behaviors that might be related to later attention problems. However, by age 5, this difference was no longer seen. This follow-up study also found no difference in communication problems, activity levels, or temperament traits (like shyness) at age 5.
If a man takes sumatriptan, could it affect fertility or increase the chance of birth defects?
Studies have not been done to see if sumatriptan could affect men’s fertility (ability to make healthy sperm) or increase the chance of birth defects. In general, exposures that fathers or sperm donors have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures at https://mothertobaby.org/fact-sheets/paternal-exposures-pregnancy/ .
Quoted from MotherToBaby Fact Sheets — Sumatriptan, published December 1, 2025. MotherToBaby states its fact sheets should not take the place of medical care and advice from your healthcare providers.
Breastfeeding is a separate question — what LactMed says about sumatriptan
More guides for Sumatriptan
Source
Other drugs: Acetaminophen · Amitriptyline · Amlodipine · Amoxicillin · Aspirin · Azithromycin · Bupropion · Cephalexin · Ciprofloxacin · Citalopram · Diphenhydramine · Doxycycline · Duloxetine · Escitalopram · all drugs.
The pregnancy information is transcribed from the drug’s FDA-approved label (§8.1) and mirrors what the label states — “insufficient data” is never rounded up to “safe.” This is general reference information, not medical advice. Whether to take any medication in pregnancy is a decision for you and your prescriber; do not start or stop a drug on your own, because an untreated condition can also carry risk.